The Efficacy Evaluation of Buckwheat Husk Extract on Cardiovascular Disease Risk Factors
ConditionCardiovascular Diseases
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20-65
SponsorTCI Co., Ltd.
About this trial
To assess the efficacy evaluation of buckwheat husk extract on cardiovascular disease risk factors
Eligibility criteria
Qualifiers
20 to 65-year-old males or non-pregnant females who are willing to sign the subject's consent.
The systolic blood pressure is 121-139 mmHg and the diastolic blood pressure is between 81-89 mmHg.
Those who are not pregnant and are willing to cooperate with contraception during the trial period.
No history of organ transplantation, epilepsy or convulsions, liver or kidney disease, malignant tumor, endocrine disease, mental disease, alcohol or drug abuse, or other major organic diseases (according to medical history).
Disqualifiers
Pregnant women.
People with a history of organ transplantation, epilepsy or convulsions, liver and kidney disease, malignant tumors, endocrine diseases, mental illness, alcohol or drug abuse, and other major organic diseases (according to medical history).
No person has undergone major surgery.
Trial design
Treatments tested in this trial
- Placebo
- Buckwheat husk extract
Treatment groups
60 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov